VSTM

Verastem, Inc. is a biopharmaceutical company committed to developing and commercializing medicines to improve the lives of patients diagnosed with cancer. The company focuses on treatments targeting critical signaling pathways in cancer cells, with a particular emphasis on therapies for RAS pathway-driven cancers and difficult-to-treat malignancies. Verastem employs precision medicine approaches to identify patients most likely to benefit from its targeted therapies.